Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice
- PMID: 14697498
- DOI: 10.1016/j.brainres.2003.10.029
Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice
Abstract
To assess the specific role of tumor necrosis factor (TNF) death receptor signaling in the induction of retinal ganglion cell (RGC) death, optic nerves of mice deficient for TNF receptor-1 (TNF-R1-/-) and control mice (C57BL/6J) were unilaterally subjected to crush injury. Counts of RGCs and their axons 6 weeks after the injury demonstrated that their loss was significantly less in TNF-R1-/- mice compared to controls. The most prominent decrease in neuronal loss detected in TNF-R1-/- mice was beyond the initial 2-week period after the injury. This time period was correlated with the period of glial activation and increased glial immunolabeling for TNF-alpha in these eyes. No further protection against neuronal loss was detectable in TNF-R1-/- mice treated with D-JNKI1, a specific inhibitor of c-Jun N-terminal protein kinase (JNK). However, anti-JNK treatment of control animals provided a significant protection against neuronal loss during the same secondary degeneration period. Phospho-JNK immunolabeling of RGCs in control mice subjected to optic nerve crush significantly decreased following their treatment with D-JNKI1, and anti-JNK treatment protected RGCs from degeneration in these animals, similar to the lack of TNF-R1. These findings provide evidence that TNF death receptor signaling is involved in the secondary degeneration of RGCs following optic nerve injury, and is associated with JNK signaling. Since secondarily degenerating neurons are viable targets for neuroprotection, inhibition of TNF death receptor signaling may be an effective strategy to protect RGCs in several neurodegenerative injuries.
Similar articles
-
Tumor necrosis factor alpha has an early protective effect on retinal ganglion cells after optic nerve crush.J Neuroinflammation. 2014 Nov 19;11:194. doi: 10.1186/s12974-014-0194-3. J Neuroinflammation. 2014. PMID: 25407441 Free PMC article.
-
Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury.Exp Eye Res. 2018 Jun;171:54-61. doi: 10.1016/j.exer.2018.03.007. Epub 2018 Mar 8. Exp Eye Res. 2018. PMID: 29526794 Free PMC article.
-
Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury.Mol Neurodegener. 2017 Oct 2;12(1):71. doi: 10.1186/s13024-017-0214-8. Mol Neurodegener. 2017. PMID: 28969695 Free PMC article.
-
TNF-alpha signaling in glaucomatous neurodegeneration.Prog Brain Res. 2008;173:409-21. doi: 10.1016/S0079-6123(08)01128-X. Prog Brain Res. 2008. PMID: 18929124 Free PMC article. Review.
-
[Inhibition of stress-responsive signaling pathway prevents neural cell death following optic nerve injury].Nippon Ganka Gakkai Zasshi. 2014 Nov;118(11):907-15. Nippon Ganka Gakkai Zasshi. 2014. PMID: 25543382 Review. Japanese.
Cited by
-
KIOM-79 protects AGE-induced retinal pericyte apoptosis via inhibition of NF-kappaB activation in vitro and in vivo.PLoS One. 2012;7(8):e43591. doi: 10.1371/journal.pone.0043591. Epub 2012 Aug 20. PLoS One. 2012. PMID: 22916281 Free PMC article.
-
Celastrol supports survival of retinal ganglion cells injured by optic nerve crush.Brain Res. 2015 Jun 3;1609:21-30. doi: 10.1016/j.brainres.2015.03.032. Epub 2015 Mar 24. Brain Res. 2015. PMID: 25813825 Free PMC article.
-
Immunomodulation as a Neuroprotective Strategy for Glaucoma Treatment.Curr Ophthalmol Rep. 2019 Jun;7(2):160-169. Epub 2019 Apr 23. Curr Ophthalmol Rep. 2019. PMID: 31360618 Free PMC article.
-
Fisetin rescues retinal functions by suppressing inflammatory response in a DBA/2J mouse model of glaucoma.Doc Ophthalmol. 2019 Apr;138(2):125-135. doi: 10.1007/s10633-019-09676-9. Epub 2019 Feb 11. Doc Ophthalmol. 2019. PMID: 30756213
-
Targets of Neuroprotection in Glaucoma.J Ocul Pharmacol Ther. 2018 Jan/Feb;34(1-2):85-106. doi: 10.1089/jop.2017.0041. Epub 2017 Aug 18. J Ocul Pharmacol Ther. 2018. PMID: 28820649 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous